AzTrials
AzTrials

Ileal Digestibility of Amino AcidsLeg4LifeNCT05047757

Amino Acid Bioavilability of Fava Beans

A study testing Test meal with 15N labeled favabean in people with Ileal Digestibility of Amino Acids, run by Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement at 1 site in France.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The goal of the project is to determine the ileal amino acid digestibility of Favabean in healthy subjects equipped with naso-ileal tube. For this purpose, Favabean will be intrinsically labelled with 15N using 15N fertilizer. Read more about this study

Who is it for?
Ages 18 to 60 yearsHealthy volunteers can take part
Conditions the study is for
Ileal Digestibility of Amino Acids
What is being tested?
Test meal with 15N labeled favabean
Could I receive a placebo?
No, everyone receives an active treatment
How many people
17 participants
Where
1 siteFrance
Study dates
18 Oct 2021to 4 Apr 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 60 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • 18<BMI<30
  • Good health (WHO=0)
  • For woman: use of birth control

Who cannot join

  • allergy against legumes
  • allergy against latex
  • pregnant women
  • Positive serology for AgHBS, AcHbc, HCV, HIV
  • Positive PCR test for SARS-Cov2
  • Anemia
Show all 11Show fewer
  • Excessive alcohool consumption
  • Hypertension, diabetes, digestive, hepatic or renal diseases, cardiac disease
  • Exercice>7h/week
  • Blood donation within 3 months before the study
  • Participation to another clinical study within 3 months before the study

Trial locations and contacts

1 site in 1 country.

France1 site
  • Centre de Recherche sur Volontaires (CRV), Hospital Avicenne

    Bobigny, Île-de-France Region, 93000

Other trials in France

About this study

Official title: Fava Bean Protein and Amino Acid Bioavailability in Healthy Volunteers

The goal of the project is to determine the ileal amino acid digestibility of Favabean in healthy subjects equipped with naso-ileal tube. For this purpose, Favabean will be intrinsically labelled with 15N using 15N fertilizer. This procedure will be realized in Finland and the labelled material will be sent to the Unit PNCA.

Read the detailed description

The objective is to determine the nutritional quality of protein from favabean in healthy humans, especially in terms of amino acid digestibility. Ileal digestibility is determined in ileal digesta collected postprandially with a naso-ileal tube. The favabeans are intrinsically labelled in 15N in order to track dietary nitrogen and amino acids in the samples.

Ethical and regulatory aspects:

The protocole was submitted to the Ethical Committee for approval and to the French Agency of Drugs and Health for administrative authorization. The personal data management will be in accordance with the regulation on personal data protection ( " regulation n° 2018-493 du 20 juin 2018").

Meal:

The meal will consist in 250 g of cooked and peeled favabean, to provide 20 g protein. Sensory tests will be realized to optimize the organoleptic properties of the meal. 15N labelled bean will be boiled in water with salt. On the morning of the experiment, the portion of fava bean will be warmed up.

Volunteers:

Eight subjects will be included in the study. The investigators plan to recruit around 16 volunteers to accommodate for the usual 50% dropouts.

One week before the experiment, the volunteers will follow a standard diet adapted to their body weight to control their protein intake (1.3 g protein/kg body weight). They will be ask to consume one to 3 portions of favabean in the week.

The volunteers will arrive at the Human Nutrition Research Centre of Avicenne Hospital on the morning before the day of the experiment. They will be equipped with a double lumen intestinal tube that will be allowed to progress through the intestinal tract for 24h. One of the lumen is radio opaque and serves to perfuse a non-absorbable maker in the intestine (slow marker method). The other lumen is dedicated to the continuous aspiration of the effluents, 15 cm below the perfusion site. The measurement of the non-absorbable marker in the effluents allows the determination of the effluent flow rate.

On the day of the experiment, the position of the tube will be checked by radiography to verify its location at the terminal ileum. A catheter will be inserted in the forearm vein for blood sampling. The perfusion of the non-absorbable marker, PEG-4000 (20g/l), will start at a flow rate of 1ml/min. The intestinal flow and the basal ileal sample will be collected during 30 min. Basal plasma sample will be sampled.

Then, at t=0, the volunteers will drink the test-meal. Until t=8h, intestinal content will be continuously collected by aspiration and pooled every 30 minutes. Blood will be sampled every 30 minutes during 4h and hourly thereafter. The urine will be collected every 2 h for 8 h.

Subjects will collect stools samples at home during the 48 h after the meal. Stools will be sent to Finland.

Measurements:

In the digesta:

PEG-4000 by turbidimetric method, total N and 15N enrichment by EA-IRMS, amino acid concentrations by UPLC (after acid hydrolysis HCl 6N at 110°C for 24h), 15N amino acid enrichment by GC-c-IRMS (after purification on cation exchange resin and derivatization).

In the plasma:

Glucose, urea (colorimetric methods), insulin (ELISA), amino acid concentrations (UPLC), 15N enrichment in plasma protein, urea and free amino acids (EA-IRMS, after purification on cation exchange resin and derivatization).

In the urine:

Urea (colorimetric method) and 15N urea (EA-IRMS, after purification on cation exchange resin and derivatization).

In the stools:

Micriobial DNA.

Outcomes:

Real ileal digestibility of protein and amino acids (digestive losses), Postprandial deamination (metabolic losses), Net Postprandial Protein Utilization, Microbiota composition.

Being tested
Test meal with 15N labeled favabean
Keywords
digestibility, healthy humans, nasoileal tubes, stable isotopes, legumes

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Test meal with 15N labeled favabeanDietary supplement

    Ingestion of a 15N labeled test meal. Subjects are equipped with a nasoileal tube. 15N is followed in biological fluids (plasma, effluents, urines).

Study groups in NCT05047757
Study groupRoleWhat they receive
Fava beanExperimentalThe intervention consists in a test meal containing 250 g of cooked and peeled favabean, to provide 20 g protein. Fava bean are intrinsically labelled with 15N.
Receives: Dietary Supplement: Test meal with 15N labeled favabean

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Ileal digestibility of protein and amino acids

    The measurement of nitrogen (mmol) and 15N enrichment (atom %) in ileal samples allow to determine the amount of dietary nitrogen in the lumen. The measurement of amino acid concentration (mmol) and their individual 15N enrichment (atom %) allow the determination of dietary amino acids remaining in the lumen.

    Dietary amino acids and dietary nitrogen that are recovered in the ileal samples are then considered as non absorbed.

    Measured: -30 minutes to 8 hours after the test meal

Secondary outcomes (6)
  1. Net Postprandial Protein Utilization (NPPU)

    The measurement of urea (mmol) and 15N enrichment of urea (atom %) allow to determine the amount of dietary N that was transferred to urea, thus accounting for metabolic losses. Metabolic losses of dietary N, together with digestive losses of dietary N, are not retained in the body.

    Measured: 0 to 8 hours after the test meal

  2. gut microbiota in response to the ingestion of 15N fava bean

    Microbial DNA sequencing

    Measured: 0 to 2 days after the test meal

  3. Nitrogen metabolites in blood in response to the ingestion of 15N fava bean

    urea and amino acids (mmol/l)

    Measured: 0 to 8 hours after the test meal

  4. Plasma glucose in blood in response to the ingestion of 15N fava bean

    plasma glucose (mmol/l)

    Measured: 0 to 8 hours after the test meal

  5. Plasma insulin in blood in response to the ingestion of 15N fava bean

    plasma insulin (pmol/l)

    Measured: 0 to 8 hours after the test meal

  6. Starch digestibility in response to the ingestion of fava bean

    The measurement of glucose from starch in ileal samples allow to determine the amount of undigested starch in the lumen.

    Measured: -30 minutes to 8 hours after the test meal

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted17 Sep 2021
  2. Study start18 Oct 2021
  3. Primary completion1 Jan 2023
  4. Study completion4 Apr 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Basic science
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
17 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05047757
Sponsor's protocol ID
Leg4LifeDIG
Acronym
Leg4Life
Status last verified
Feb 2024
First submitted
15 Jun 2021
Last updated
22 Feb 2024
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Itkonen ST, Calvez J, Airinei G, Chapelais M, Khodorova N, Sahaka M, Benamouzig R, Stoddard FL, Simojoki A, Pajari AM, Gaudichon C. True Ileal Amino Acid Digestibility and Protein Quality of 15N-Labeled Faba Bean in Healthy Humans. J Nutr. 2024 Apr;154(4):1165-1174. doi: 10.1016/j.tjnut.2024.01.030. Epub 2024 Feb 3.

    PubMed 38311065

Questions about this trial

What is this clinical trial studying?

A study testing Test meal with 15N labeled favabean in people with Ileal Digestibility of Amino Acids, run by Institut National de Recherche pour l'Agriculture, l'Alimentation et l'Environnement at 1 site in France.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 11 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 22 Feb 2024. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in France. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Ileal digestibility of protein and amino acids (time frame: -30 minutes to 8 hours after the test meal). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05047757, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Feb 2024.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in